Trademark: 97414523
Word
CANCER VISION
Status
Pending
Status Code
653
Status Date
Thursday, May 11, 2023
Serial Number
97414523
Mark Type
4000
Filing Date
Tuesday, May 17, 2022

Trademark Owner History

Classifications
9 Downloadable computer software for provision of genetic information; downloadable computer software for processing genetic sequence information; downloadable computer software for navigating genetic information; downloadable computer software for analyzing genetic information; downloadable computer software for use in genetic information interpretation; laboratory apparatus namely, DNA analysis apparatus; laboratory apparatus namely, DNA sequencing devices; laboratory apparatus namely, genetic sequence information processing device; laboratory apparatus namely, genetic information navigating device; laboratory apparatus namely, genetic information analyzing device; laboratory apparatus namely, genetic information interpretation device; downloadable computer software for diagnosing cancer for medical purposes; downloadable computer software for diagnosing diseases for medical purposes; downloadable computer software for use in medical decision support systems
44 Medical and pharmaceutical consultation namely, consultancy and information services relating to biopharmaceutical products; medical services namely, medical and health services relating to DNA, genetics and genetic testing; genetic testing for medical purposes; medical services namely, provision of genetic information for medical treatment purposes; Genetic testing of animals for diagnostic or treatment purposes; psychological consultation; beauty consultation services in the selection and use of cosmetics; consultancy services relating to beauty; providing information about beauty; health spa services namely, cosmetic body care services; pharmaceutical advice; medical services namely, analysis of human biodata for medical purposes; medical services namely, provision of genetic testing for medical treatment purposes; medical services namely, provision of gene therapy for medical treatment purposes
42 Consultancy relating to research in the field of pharmacogenetics; scientific laboratory services namely, solvent testing services; scientific research in the field of genetic engineering; laboratory research in the field of gene expression; scientific research namely, research in the field of gene analysis; genetic testing for scientific research purposes namely, genetic fingerprinting; scientific research in the field of genetics and genetic engineering; scientific research in the field of genetics; scientific research namely, genetic research; genetic testing for scientific research purposes; scientific research; web site design; creating and designing website-based indexes of information for others using information technology; product research namely, research into new products; provision of internet search engines; database development services; development, programming, and implementation of software for others; scientific research namely, research and testing services in the fields of bacteriology and virology; remote monitoring of medical data for medical diagnosis namely, technical and scientific monitoring services relating to medical diagnostic instruments; structural and functional analysis of genomes
"CANCER"

Trademark Events
Feb 16, 2024
Suspension Checked - To Attorney For Action
Feb 15, 2024
Assigned To Examiner
Jan 5, 2024
Suspension Checked - To Attorney For Action
May 11, 2023
Notification Of Letter Of Suspension E-Mailed
May 11, 2023
Letter Of Suspension E-Mailed
May 11, 2023
Suspension Letter Written
Mar 31, 2023
Teas/Email Correspondence Entered
Mar 31, 2023
Correspondence Received In Law Office
Mar 31, 2023
Teas Response To Office Action Received
Mar 13, 2023
Notification Of Non-Final Action E-Mailed
Mar 13, 2023
Non-Final Action E-Mailed
Mar 13, 2023
Non-Final Action Written
Mar 6, 2023
Assigned To Examiner
May 24, 2022
New Application Office Supplied Data Entered
May 20, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24